September 21, 2014 12:52 PM ET

Biotechnology

Company Overview of Hybritech, Inc.

Company Overview

Hybritech, Inc., a biotechnology company, develops, and markets monoclonal antibodies which are used in making diagnostic and medical monitoring tests to identify a variety of infectious, viral and cancer-related diseases including colon and prostate cancer, infertility, allergies, and pregnancy. The company was founded in 1978 and is based in San Diego, California. Hybritech, Inc. operates as a subsidiary of Danaher Corp.

PO Box 269006

San Diego, CA 92196-9006

United States

Founded in 1978

Phone:

619-455-6700

Fax:

619-453-4124

Key Executives for Hybritech, Inc.

Hybritech, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
StormBio, Inc. United States
Oncotide Pharmaceuticals Inc United States
Stemgent, Inc. United States
Pivotal BioSciences, Inc. United States
Aramed, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Hybritech, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.